Literature DB >> 28060227

Preoperative Opioid Use Is Associated with Early Revision After Total Knee Arthroplasty: A Study of Male Patients Treated in the Veterans Affairs System.

Alon Ben-Ari1, Howard Chansky, Irene Rozet.   

Abstract

BACKGROUND: Opioid use is endemic in the U.S. and is associated with morbidity and mortality. The impact of long-term opioid use on joint-replacement outcomes remains unknown. We tested the hypothesis that use of opioids is associated with adverse outcomes after total knee arthroplasty (TKA).
METHODS: We performed a retrospective analysis of patients who had had TKA within the U.S. Veterans Affairs (VA) system over a 6-year period and had been followed for 1 year postoperatively. The length of time for which an opioid had been prescribed and the morphine equivalent dose were calculated for each patient. Patients for whom opioids had been prescribed for >3 months in the year prior to the TKA were assigned to the long-term opioid group. A natural language processing-based machine-learning classifier was developed to classify revisions due to infectious and non-infectious causes on the basis of the postoperative note. Survival curves for the time to knee revision or manipulation were used to compare the long-term opioid group with the patients who did not take opioids long-term. Hazard and odds ratios for knee revision and manipulation were obtained as well.
RESULTS: Of 32,636 patients (94.4% male; mean age [and standard deviation], 64.45 ± 9.41 years) who underwent TKA, 12,772 (39.1%) were in the long-term opioid group and 734 (2.2%) had a revision within a year after the TKA. Chronic kidney disease, diabetes, and long-term opioid use were associated with revision within 1 year-with odds ratios (95% confidence intervals [CIs]) of 1.76 (1.37 to 2.22), 1.11 (0.93 to 1.31), and 1.40 (1.19 to 1.64), respectively-and were also the leading factors associated with a revision at any time after the index TKA-with odds ratios (95% CIs) of 1.61 (1.34 to 1.92), 1.21 (1.08 to 1.36), and 1.28 (1.15 to 1.43), respectively. Long-term opioid use had a hazard ratio of 1.19 (95% CI = 1.10 to 0.24) in the analysis of its relationship with knee revision, but the hazard was not significant in the analysis of its association with knee manipulation. The accuracy of the text classifier was 0.94, with the area under the receiver operating characteristic curve being 0.99. There was no association between long-term use of opioids and the specific cause for knee revision.
CONCLUSIONS: Long-term opioid use prior to TKA was associated with an increased risk of knee revision during the first year after TKA among predominantly male patients treated in the VA system. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28060227     DOI: 10.2106/JBJS.16.00167

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  27 in total

1.  Excess Opioid Medication and Variation in Prescribing Patterns Following Common Orthopaedic Procedures.

Authors:  Matthew J Sabatino; Samuel T Kunkel; Dipak B Ramkumar; Benjamin J Keeney; David S Jevsevar
Journal:  J Bone Joint Surg Am       Date:  2018-02-07       Impact factor: 5.284

2.  Evaluation of opioid discontinuation after non-orthopaedic surgery among chronic opioid users: a population-based cohort study.

Authors:  Naheed K Jivraj; Damon C Scales; Tara Gomes; Jennifer Bethell; Andrea Hill; Ruxandra Pinto; Duminda N Wijeysundera; Hannah Wunsch
Journal:  Br J Anaesth       Date:  2020-01-27       Impact factor: 9.166

3.  Incidence and Risk Factors for Chronic Postoperative Opioid Use After Major Spine Surgery: A Cross-Sectional Study With Longitudinal Outcome.

Authors:  Lauren K Dunn; Sandeep Yerra; Shenghao Fang; Mark F Hanak; Maren K Leibowitz; Siny Tsang; Marcel E Durieux; Edward C Nemergut; Bhiken I Naik
Journal:  Anesth Analg       Date:  2018-07       Impact factor: 5.108

Review 4.  Chronic Opioid Use After Surgery: Implications for Perioperative Management in the Face of the Opioid Epidemic.

Authors:  Jennifer M Hah; Brian T Bateman; John Ratliff; Catherine Curtin; Eric Sun
Journal:  Anesth Analg       Date:  2017-11       Impact factor: 5.108

5.  Accuracy of self-reported opioid use in orthopaedic trauma patients.

Authors:  Fady Y Hijji; Tyler Sanda; Scott D Huff; Andrew W Froehle; Joseph D Henningsen; Andrew D Schneider; Joseph G Lyons; Humza M Mian; Jennifer Jerele; Indresh Venkatarayappa
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-01-04

6.  Predicting surgical operative time in primary total knee arthroplasty utilizing machine learning models.

Authors:  Ingwon Yeo; Christian Klemt; Christopher M Melnic; Meghan H Pattavina; Bruna M Castro De Oliveira; Young-Min Kwon
Journal:  Arch Orthop Trauma Surg       Date:  2022-08-22       Impact factor: 2.928

Review 7.  Management of Opioid-Tolerant Patients with Acute Pain: Approaching the Challenges.

Authors:  Pamela E Macintyre; Lindy J Roberts; Christine A Huxtable
Journal:  Drugs       Date:  2020-01       Impact factor: 9.546

8.  Minimizing Opioids After Joint Operation: Protocol to Decrease Postoperative Opioid Use After Primary Total Knee Arthroplasty.

Authors:  Erik Woelber; Lindsey Wurster; Sarah Brandt; Patricia Mecum; Kenneth Gundle; Lucas Anissian
Journal:  Fed Pract       Date:  2021-02

9.  Multi-modal pain control regimen for anterior lumbar fusion drastically reduces in-hospital opioid consumption.

Authors:  Yoji Ogura; Jeffrey L Gum; Portia Steele; Charles H Crawford; Mladen Djurasovic; R Kirk Owens; Joseph L Laratta; Eric Davis; Morgan Brown; Christy Daniels; John R Dimar; Steven D Glassman; Leah Y Carreon
Journal:  J Spine Surg       Date:  2020-12

10.  Prevalence of Prescription Opioids for Nonoperative Treatment of Rotator Cuff Disease Is High.

Authors:  Jacob Gorbaty; Susan M Odum; Meghan K Wally; Rachel B Seymour; Nady Hamid; Joseph R Hsu; Michael Beuhler; Michael J Bosse; Michael Gibbs; Christopher Griggs; Steven Jarrett; Daniel Leas; Tamar Roomian; Michael Runyon; Animita Saha; Bradley Watling; Stephen Wyatt; Ziqing Yu
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.